Results for the substance atogepant

Atogepant is a medication used for the prevention of episodic migraines in adults. It belongs to a class of drugs called CGRP receptor antagonists (calcitonin gene-related peptide), which work by blocking the activity of CGRP, a substance involved in the development of migraines.

It is taken orally in tablet form and is intended for daily use to reduce the frequency and severity of migraine episodes. Atogepant is well-tolerated by most patients, with reported side effects including nausea, fatigue, and constipation.

This medication is recommended for patients who experience frequent migraines and do not respond well to other preventive treatments. It is important to use it as directed by a healthcare provider, and patients should inform their doctor of any side effects or other medications they are taking.